Log in or Sign up for Free to view tailored content for your specialty!
Glaucoma News
Santen, Glaukos enter MicroShunt distribution agreement
Glaukos will be the exclusive distributor of Santen’s MicroShunt in the United States, the companies announced.
Trial supports SLT as first-line treatment for glaucoma, ocular hypertension
In a large 3-year trial, selective laser trabeculoplasty showed better control of IOP and better cost-effectiveness than eye drops as a first-line treatment for glaucoma and ocular hypertension. According to the authors, these findings suggest that selective laser trabeculoplasty (SLT) should be offered as a first-line treatment, supporting a change in clinical practice.
Log in or Sign up for Free to view tailored content for your specialty!
Novaliq and BLP form Betaliq to develop glaucoma products
Novaliq and BLP Management Group have formed Betaliq, a company that will develop beta-blockers for the treatment of glaucoma, according to a press release.
CTR-blocked angle increases IOP in chronic hypotony
Patients who underwent a novel surgical method to treat chronic ocular hypotony experienced increased IOP and visual acuity through a mean 27.7-month follow-up period, according to a study.
Fit individuals experience more stable IOP during exercise
Individuals with high fitness levels show lower IOP and ocular perfusion pressure during a maximal treadmill text compared to individuals of a lower fitness level, whose IOP and ocular perfusion pressure increased, according to a study published in the European Journal of Ophthalmology.
Rocklatan approval tops recent glaucoma news
The FDA’s approval of Rocklatan and news updates from the American Glaucoma Society meeting were among the most-read glaucoma-related articles on Healio.com/OSN in recent weeks.
New technologies bring better ways to treat glaucoma
If you fly at all, you can’t help but be a bit unsettled in the wake of two commercial airline tragedies over the past 6 months. What’s even more concerning is that both involved the same aircraft, the Boeing 737 Max 8.
Experts say future of glaucoma treatment may lie in sustained release
“As we are able to diagnose glaucoma earlier and earlier and have a better understanding of the disease, it will help to determine the most appropriate therapy for the individual patient, whether that is drops, sustained release or surgical intervention,” private practitioner Chris Wroten, OD, told Primary Care Optometry News.
CyPass migration uncommon, says glaucoma surgeon
With proper anatomic placement of the CyPass Micro-Stent, postimplantation migration of a supraciliary device is not common, according to Shakeel Shareef, MD, professor at the University of Rochester School of Medicine and surgeon at the Flaum Eye Institute.
VIDEO: Wellness exam provides personalized baseline
NEW YORK – Performing a wellness exam provides baseline information “that helps us make clinical decisions based on a patient’s health status being positive rather than being negative,” Aaron Lech, OD, said here at Vision Expo East.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read